SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-214740
Filing Date
2019-08-07
Accepted
2019-08-07 09:10:03
Documents
14
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788906d8k.htm   iXBRL 8-K 29907
2 EX-99.1 d788906dex991.htm EX-99.1 43671
6 GRAPHIC g788906g0807071232160.jpg GRAPHIC 3627
  Complete submission text file 0001193125-19-214740.txt   213714

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20190807.xsd EX-101.SCH 3084
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20190807_lab.xml EX-101.LAB 18904
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20190807_pre.xml EX-101.PRE 11871
7 EXTRACTED XBRL INSTANCE DOCUMENT d788906d8k_htm.xml XML 3334
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 191004052
SIC: 2834 Pharmaceutical Preparations